App-Quantinova.ai

A Novel Human Arterial Transcriptomic Signature Associated With Major Adverse Cardiovascular Events and Oxidative Stress

Christos Kotanidis - American Heart Association (AHA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Myocardial infarction

N/A

The microRNA-378 and Estrogen-Related Receptor Gamma Axis Regulates Metabolic Inflammation and Lipoprotein Metabolism: A Potential Therapeutic Target for Atherosclerosis

Qiaozhu Su - American Heart Association (AHA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

Mitochondrial Metabolites Predict Cardiovascular Outcomes and Heart Failure in Individuals with Type 2 Diabetes Mellitus: An Exscel Biomarker Substudy

Jessica A Regan - American Heart Association (AHA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Type 2 diabetes mellitus

Sitagliptin

Analytical Validation for an Integrated Risk Tool for Cardiovascular Disease Combining Conventional Risk Factors and Polygenic Risk Inferred from Snp Array and Low-Pass Whole Genome Sequencing

Carla Giner Delgado - American Heart Association (AHA) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

Clinical Implications of Integrating Polygenic Risk Into Established Cardiovascular Disease Risk Scores

Fernando Riveros-Mckay - American Heart Association (AHA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

Genetic Overlap of Acute Myocarditis and Inherited Cardiomyopathy

Amrit S Lota - American Heart Association (AHA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Fulminant myocarditis

N/A

Impact of Sex on Outcomes After Cardiac Surgery: A Systematic Review and Meta-Analysis

Lauren K Dixon - American Heart Association (AHA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Myocardial infarction

N/A

Sex Differences in Outcomes After Cardiac Surgery: Insights From a National Database

Lauren Dixon - American Heart Association (AHA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Renal insufficiency

N/A

Myocardial Physiological Responses to the Third Trimester of Healthy Pregnancy

Sharmaine Thirunavukarasu - American Heart Association (AHA) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

Effect of Cardiovascular Risk Factors on Hypertensive Disorders of Pregnancy: A Mendelian Randomization Study

Maddalena Ardissino - American Heart Association (AHA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Preeclampsia

N/A

Perioperative Physician Care Model in Cardiothoracic Surgery: A Pilot Study

Rosie Freer - American Heart Association (AHA) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

Mathematical Model for Predicting Survival in Elderly (Above 80 Years) Population After Primary Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction

Aaruni Saxena - American Heart Association (AHA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

N/A

Sex Differences in Diabetic Cardiomyopathy: Greater Reduction in Myocardial Perfusion Reserve in Women Than Men Driven by Increased Resting Perfusion

Jian L Yeo - American Heart Association (AHA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Diabetic cardiomyopathy

Adenosine

Prediction of 30-Day Hospital Readmission in High-Risk Atherosclerotic Cardiovascular Disease Patients Using Machine Learning Methods on Electronic Health Record Data from Medical Information Mart for Intensive Care-3 Database

Nitin Kumar Garg - American Heart Association (AHA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

Albuminuria in Heart Failure is More Strongly Associated with Markers of Congestion Than Renal Dysfunction

Eva M Boorsma - American Heart Association (AHA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Arrhythmia

N/A

Transthyretin Amyloid Cardiomyopathy Associated With the P.V142I Transthyretin Variant is an Inherently Aggressive Form of Transthyretin Amyloid Cardiomyopathy Associated With Significant Functional Impairment and Poor Prognosis

Yousuf Razvi - American Heart Association (AHA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Transthyretin cardiac amyloidosis

N/A

Prospective Utility of ST2 in Patients Hospitalized With Acute Decompensated Heart Failure

Brian Li - American Heart Association (AHA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Acute decompensated heart failure

N/A

Cardiac Allograft Vasculopathy Following Donation After Circulatory-Determined Death Heart Transplantation

Caitlin Cheshire - American Heart Association (AHA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Cardiac allograft vasculopathy

N/A

Identification of a Proteomic Signature Showing Ongoing Inflammation in Severe Rheumatic Heart Disease

Taariq M Salie - American Heart Association (AHA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Rheumatic heart disease

Penicillin

Biological Sex as a Modifier of the Natural History of Dilated Cardiomyopathy

Upasana Tayal - American Heart Association (AHA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Dilated cardiomyopathy

N/A

Filters

45280 Abstracts